From the portfolio
In the second part of the evening, founders from Fund I and Fund II presented their companies.
Eva van Rikxoort, founder and CEO of Thirona (NL), made the case for lung disease. Alongside cancer and cardiovascular disease, it’s one of the largest health challenges we face. Thirona develops AI-powered software that provides high-precision medical image analysis, specifically chest CT scans and X-rays.
Enric Gibert, Founder of Pharmacelera (ES), explained how the company combines quantum mechanics algorithms with artificial intelligence to develop software that speeds up the design–make–test–analyse (DMTA) cycle at the heart of drug discovery.
Bringing it closer to home, Stijn Verhulst, Head of Paediatrics at Antwerp University Hospital, spoke about Project Oever, an initiative that HERAN supports. It connects hospital, family, and primary care so that children with severe illness can receive the care they need at home. Although our roles are different, both HERAN and Project Oever share a common purpose: enabling better healthcare by connecting the right expertise, people and resources.
The evening ended with a walking dinner and engaging conversations.
The companies we invest in have moved forward, but our story remains the same. Building a company in this sector is not a sprint; it’s a marathon. We intend to run it alongside our founders.
Thank you to everyone who joined us. We look forward to seeing you next year.